diabetes mellitus, type 2

Showing NaN - NaN of 139

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Diabetes, Type 2 Trial in Canada, United States (ITCA 650 20/60 mcg/day, Empagliflozin (oral), Glimepiride (oral))

Terminated
  • Diabetes Mellitus, Type 2
  • ITCA 650 20/60 mcg/day
  • +2 more
  • Fountain Hills, Arizona
  • +100 more
Mar 4, 2019

Diabetes, Type 2, Albuminuria Trial in Worldwide (Placebo, Canagliflozin, 100 mg, Canagliflozin, 300 mg)

Completed
  • Diabetes Mellitus, Type 2
  • Albuminuria
  • Placebo
  • +2 more
  • Little Rock, Arkansas
  • +353 more
Nov 19, 2018

Diabetes, Type 2 Trial in South Miami, High Point, Toronto (LY3209590, Insulin Glargine)

Completed
  • Diabetes Mellitus, Type 2
  • South Miami, Florida
  • +2 more
Dec 10, 2018

Diabetes, Type 2, Cardiovascular Diseases, Risk Factors Trial in Worldwide (Placebo, Canagliflozin (JNJ-28431754) 100 mg,

Completed
  • Diabetes Mellitus, Type 2
  • +2 more
  • Placebo
  • +2 more
  • Birmingham, Alabama
  • +312 more
Nov 5, 2018

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, sitagliptin, )

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Phoenix, Arizona
  • +105 more
Sep 3, 2018

Diabetes, Type 2, Schizophrenia Trial in Toronto (Metformin, Placebo)

Completed
  • Diabetes Mellitus, Type 2
  • Schizophrenia
  • Toronto, Ontario, Canada
    Center for Addiction and Mental Health
Jul 27, 2018

Diabetes, Type 2 Trial in Worldwide (GSK523338)

Completed
  • Diabetes Mellitus, Type 2
  • Tucson, Arizona
  • +84 more
Apr 2, 2018

Meta-analysis of Pulses/Legumes and Incident Cardiometabolic

Unknown status
  • Cardiovascular Diseases
  • +5 more
  • Dietary pulses or legumes
  • Toronto, Ontario, Canada
    The Toronto 3D (Diet, Digestive tract and Disease) Knowledge Syn
Jun 12, 2018

Diabetes, Type 2 Trial in Worldwide (Glargine, LY2605541)

Completed
  • Diabetes Mellitus, Type 2
  • Anniston, Alabama
  • +166 more
Mar 16, 2018

Diabetes, Type 2 Trial in Worldwide (Placebo, DEN 2.5 mg, DEN 7.5 mg)

Completed
  • Diabetes Mellitus, Type 2
  • Placebo
  • +5 more
  • Long Beach, California
  • +108 more
Mar 19, 2018

Diabetes, Type 2 Trial in Canada (rosiglitazone/metformin)

Completed
  • Diabetes Mellitus, Type 2
  • Calgary, Alberta, Canada
  • +90 more
Mar 19, 2018

Diabetes, Type 2 Trial in Worldwide (rosiglitazone maleate/metformin HCl)

Completed
  • Diabetes Mellitus, Type 2
  • rosiglitazone maleate/metformin hydrochloride
  • Anniston, Alabama
  • +101 more
Mar 19, 2018

Diabetes, Type 2 Trial in Worldwide (rosiglitazone/metformin)

Completed
  • Diabetes Mellitus, Type 2
  • Anniston, Alabama
  • +93 more
Mar 19, 2018

Diabetes, Type 2 Trial in Worldwide (Insulin Pump (Medtronic Minimed Paradigm® VEO))

Completed
  • Diabetes Mellitus, Type 2
  • Insulin Pump (Medtronic Minimed Paradigm® VEO)
  • Atlanta, Georgia
  • +35 more
Feb 6, 2018

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin degludec, liraglutide)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/liraglutide
  • +2 more
  • Birmingham, Alabama
  • +301 more
Feb 16, 2018

Diabetes, Type 2 Trial in Worldwide (Rosiglitazone, glyburide, metformin)

Completed
  • Diabetes Mellitus, Type 2
  • Anniston, Alabama
  • +489 more
Nov 27, 2017

Diabetes, Type 2 Trial in Worldwide (GSK189075, Placebo)

Completed
  • Diabetes Mellitus, Type 2
  • Mesa, Arizona
  • +156 more
Sep 26, 2017

Type 2 Diabetes Mellitus inUsual Clinical Practice in Canada

Completed
  • Diabetes Mellitus, Type 2
  • No Intervention
  • Calgary, Alberta, Canada
  • +22 more
Oct 27, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, )

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/liraglutide
  • placebo
  • Anaheim, California
  • +86 more
Sep 26, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec, , liraglutide)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec
  • +2 more
  • Anaheim, California
  • +131 more
Aug 25, 2017

Diabetes, Type 2 Trial in Worldwide (pioglitazone, rosiglitazone, )

Terminated
  • Diabetes Mellitus, Type 2
  • Long Beach, California
  • +330 more
Mar 21, 2017

Diabetes, Type 2 Trial in Worldwide (Pioglitazone, GW677954)

Completed
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +142 more
Mar 21, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin detemir, sitagliptin, metformin)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin detemir
  • +3 more
  • Vestavia, Alabama
  • +50 more
Feb 2, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, sitagliptin, metformin)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +165 more
Jan 25, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, )

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Phoenix, Arizona
  • +85 more
Jan 25, 2017